Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1-42) into rat brain: Implications for Alzheimer's disease

Neuroscience

Volumn 132, Issue 2, 2005, Pages 313-324

  Boyd Kimball, D ^a   Sultana, R ^a   Fai Poon, H ^a   Lynn, B C ^a   Casamenti, F ^c   Pepeu, G ^c   Klein, J B ^d   Butterfield, D A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide (1 42); Neurodegeneration; Oxidative stress; Proteomics

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SYNUCLEIN; GLUTAMATE AMMONIA LIGASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHOSPHOGLYCERATE MUTASE; PYRUVATE DEHYDROGENASE; SODIUM CHLORIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; NERVE DEGENERATION; NONHUMAN; OLIVARY NUCLEUS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RAT;

EID: 15744387176     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.12.022     Document Type: Article

References (65)

1. A. Agarwal-Mawal, H.Y. Qureshi, P.W. Cafferty, Z. Yuan, D. Han, R. Lin, H.K. Paudel 14-3-3 Connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex J Biol Chem 278 2003 12722 12728
2. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383
3. M.Y. Aksenov, H.M. Tucker, P. Nair, M.V. Askenova, D.A. Butterfield, S. Estus, W.R. Markesbery The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase in different brain regions in Alzheimer's disease brain Neurochem Res 24 1999 767 774
4. J.P. Blass, G.E. Gibson The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease Rev Neurol 147 1991 513 525
5. P. Bozner, G.L. Wilson, N.M. Druzhyna, T.K. Bryant-Thomas, S.P. LeDoux, G.L. Wilson, M.A. Pappolla Deficiency of chaperonin 60 in Down's syndrome J Alzheimers Dis 4 2002 479 486
6. P.R. Burkhard, J.C. Sanchex, T. Landis, D.F. Hochstrasser CSF detection of the 14-3-3 protein in unselected patients with dementia Neurology 56 2001 1528 1533
7. D.A. Butterfield Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity implications for neurodegeneration in Alzheimer's disease brain Free Radic Res 36 2002 1307 1313
8. D.A. Butterfield Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain mechanisms and consequences Curr Med Chem 10 2003 2651 2659
9. D.A. Butterfield Proteomics a new approach to study oxidative stress in Alzheimer's disease brain Brain Res 1000 2004 1 7
10. D.A. Butterfield, J. Drake, C. Pocernich, A. Castegna Evidence of oxidative damage in Alzheimer's disease brain central role for amyloid beta-peptide Trends Mol Med 7 2001 548 554
11. D.A. Butterfield, C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Rad Biol Med 32 2002 1050 1060
12. D.A. Butterfield, E.R. Stadtman Protein oxidation processes in aging brain Adv Cell Aging Gerontol 2 1997 161 191
13. F. Casamenti, C. Prosperi, C. Scali, L. Giovanelli, M.A. Colivicchi, M.S. Faussone-Pelligrini, G. Pepeu Interleukin-1 β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo implication for Alzheimer's disease Neuroscience 91 1999 831 842
14. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Marksbery, D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain part I creatine kinase BB, glutamine synthetase, and ubiquitin carboxy-terminal hydrolase L-1 Free Rad Biol Med 33 2002 562 571
15. A. Castegna, M. Aksenov, Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part II. Dihydropyrimidinase- related protein 2, α-enolase, and heat shock cognate 71 J Neurochem 82 2002 1524 1532
16. A. Castegna, V. Thongboonkerd, J. Klein, B.C. Lynn, Y.L. Wang, H. Osaka, K. Wada, D.A. Butterfield Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins J Neurochem 88 2004 1540 1546
17. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 2003 1394 1401
18. J. Choi, A.I. Levey, S.T. Weintraub, H.D. Rees, M. Gearing, L.-S. Chin, L. Li Oxidative modifications and down regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J Biol Chem 279 2004 13256 13264
19. J. Choi, C.A. Malakowsky, J.M. Talent, C.C. Conrad, C.A. Carrll, S.T. Weintraub, R.W. Gracy Anti-apoptotic proteins are oxidized y Ab25-35 in Alzheimer's fibroblasts Biochim Biophys Acta 1637 2003 135 141
20. M.K. Dougherty, D.K. Morrison Unlocking the code of 14-3-3 J Cell Sci 117 2004 1875 1884
21. J. Drake, C.D. Link, D.A. Butterfield Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model Neurobiol Aging 24 2003 415 420
22. H. Esterbauer, R.J. Schaur, H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Rad Biol Med 11 1991 81 128
23. M. Fountoulakis, N. Cairns, G. Lubec Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome J Neural Transm Suppl 57 1999 323 335
24. S.A. Frautschy, A. Baird, G.M. Cole Effects of injection of Alzheimer β-amyloid cores in rat brain Proc Natl Acad Sci USA 88 1991 8362 8366
25. L. Frölich The cholinergic pathology in Alzheimer's disease discrepancies between clinical experience and pathophysiological findings J Neural Transm 109 2002 1003 1014
26. G.E. Gibson, K.F. Sheu, J.P. Blass, A. Baker, K.C. Carlson, B. Harding, P. Perrino Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease Arch Neurol 45 1988 836 840
27. L. Giovannelli, C. Scali, M.S. Faussone-Pelligrini, G. Pepeu, F. Casamenti Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain Neuroscience 87 1998 349 357
28. M.G. Giovannini, C. Scali, C. Prosperi, A. Bellucci, M.G. Vannucchi, S. Rosi, G. Pepeu, F. Casamenti β-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo involvement of the p38MAPK pathway Neurobiol Dis 11 2002 257 274
29. C.A. Grimes, R.S. Jope The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog Neurobiol 65 2001 391 426
30. M. Hashiguchi, K. Sobue, H.K. Paudel 14-3-3 Zeta is an effector of tau protein phosphorylation J Biol Chem 275 2000 25247 25254
31. Hashimoto M, Baron P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E (2004) β-Synuclein regulateds Akt activity in neuronal cells: a possible mechanism for neuroprotection in Parkinson's disease. J Biol Chem, published online March 16 2004.
32. K. Hensley, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, P. Gabbita, J.F. Wu, J.M. Carney, M. Lovell, W.R. Markesbery, D.A. Butterfield Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation J Neurochem 65 1995 2146 2156
33. F. Hernández, R. Cuadros, J. Avila Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers Neurosci Lett 357 2004 143 146
34. P. Iwangoff, R. Armbruster, A. Enz, W. Meier-Ruge Glycolytic enzymes from human autoptic brain cortex normal aged and demented cases Mech Ageing Dev 14 1980 203 209
35. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, D.A. Butterfield The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain the role of Abeta 1- 42 J Neurochem 78 2001 413 416
36. R. Layfield, J. Fergusson, A. Aitken, J. Lowe, M. Landon, R.J. Mayer Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins Neurosci Lett 209 1996 57 60
37. R.L. Levine, J.A. Williams, E.R. Stadtman, E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol 233 1994 346 357
38. J.Y. Li, P. Henning Jensen, A. Dahlstrom Differential localization of α-, β-, and γ-synucleins in the rat CNS Neuroscience 113 2002 463 478
39. K.M. Lin, B. Lin, I.Y. Lian, R. Mestril, I.E. Scheffler, W.H. Dillmann Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation Circulation 103 2001 1787 1792
40. M.A. Lovell, C. Xie, W.R. Markesbery Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures Neurobiol Aging 22 2001 187 194
41. R.J. Mark, M.A. Lovell, W.R. Markesbery, K. Uchida, M.P. Mattson A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide J Neurochem 68 1997 255 264
42. W.R. Markesbery, M.A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol Aging 19 1998 33 36
43. E. Masliah, M. Alford, R. DeTeresa, M. Mallory, L. Hansen Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease Ann Neurol 40 1996 759 766
44. E. Masliah, M. Mallory, L. Hansen, R. De Teresa, M. Alford, R. Terry Synaptic and neuritic alterations during the progression of Alzheimer's disease Neurosci Lett 174 1994 67 72
45. J.L. Mazzola, M.A. Sirover Reduction of glyceraldehydes-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts J Neurochem 76 2001 442 449
46. C. Messier, M. Gagnon Glucose regulation and brain aging J Nutr Health Aging 4 2000 208 213
47. H. Mohmmad-Abdul, G.L. Wenk, M. Grammling, B. Hauss-Wegrzyniak, D.A. Butterfield APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol Neurosci Letts 368 2004 148 150
48. S. Nakajo, K. Tsukada, K. Omata, K. Nakamura A new brain-specific 14 kd protein is a phosphoprotein its complete amino acid sequence and evidence for phosphorylation Eur J Biochem 217 1993 1057 1063
49. M. Ogawa, H. Fukuyama, Y. Ouchi, H. Yamauchi, J. Kimura Altered energy metabolism in Alzheimer's disease J Neurol Sci 139 1996 78 82
50. L. Parnetti, A. Gaiti, M.C. Polidori, M. Brunetti, B. Palumbo, F. Chionne, D. Cadini, R. Checchetti, U. Senin Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease Neurosci Lett 199 1995 231 233
51. L. Parnetti, G.P. Reboldi, V. Gallai Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia Neurology 54 2000 735 737
52. G. Paxinos, C. Watson The rat brain in stereotaxic coordinates 1998 Academic Press New York
53. C.B. Pocernich, D.A. Butterfield Acrolien inhibits NADH-linked mitochondrial enzyme activity implications for Alzheimer's disease Neurotox Res 5 2003 515 520
54. P. Scheltens, E.S.C. Korf Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias Curr Opin Neurol 13 2000 391 396
55. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L.M. Faull, G.J.S. Cooper Proteomic analysis of the brain in Alzheimer's disease molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
56. D.J. Selkoe Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein J Alzheimers Dis 3 2001 75 80
57. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, D.A. Butterfield The lipid peroxidation product, 4-hydroxy-2-trans- nonenal, alters the conformation of cortical synaptosomal membrane protein J Neurochem 69 1997 1161 1169
58. Y. Takahashi The 14-3-3 proteins gene, gene expression, and function Neurochem Res 28 2003 1265 1273
59. V. Thongboonkerd, J. Luengpailin, J. Cao, Q.M. Pierce, J. Cai, J.B. Klein, R.J. Doyle Fluoride exposure attenuates expression of Streptococcus pyrogenes virulence factors J Biol Chem 277 2002 16599 16605
60. M. Vanhanen, H. Soininen Glucose intolerance, cognitive impairment and Alzheimer's disease Curr Opin Neurol 11 1998 673 677
61. S. Varadarajan, S. Yatin, M. Aksenova, D.A. Butterfield Review Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity J Struct Biol 130 2000 184 208
62. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, M.R. Delong Alzheimer's disease evidence for selective loss of cholinergic neurons in the nucleus basalis Ann Neurol 10 1981 122 126
63. S.M. Yatin, S. Varadarajan, C.D. Link, D.A. Butterfield In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42) Neurobiol Aging 20 1999 325 330
64. S.M. Yatin, S. Varadarajan, D.A. Butterfield Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced protein oxidation and reactive oxygen species formation J Alzheimer's Dis 2 2000 123 131
65. B.C. Yoo, S.H. Kim, N. Cairns, M. Fountoulakis, G. Lubec Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease Biochem Biophys Res Commun 280 2001 249 258